BRPI0514469A - moduladores de androgênio - Google Patents
moduladores de androgênioInfo
- Publication number
- BRPI0514469A BRPI0514469A BRPI0514469-8A BRPI0514469A BRPI0514469A BR PI0514469 A BRPI0514469 A BR PI0514469A BR PI0514469 A BRPI0514469 A BR PI0514469A BR PI0514469 A BRPI0514469 A BR PI0514469A
- Authority
- BR
- Brazil
- Prior art keywords
- androgen
- modulators
- androgen modulators
- compound
- phenoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
MODULADORES DE ANDROGêNIO. A presente invenção refere-se a um composto 4-(2-metóxi-fenóxi)-2-trifluorometil-benzonitrila, a seu uso como um modulador de androgênio e a composições farmacêuticas contendo este composto.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60256004P | 2004-08-18 | 2004-08-18 | |
PCT/IB2005/002832 WO2006018732A1 (en) | 2004-08-18 | 2005-08-05 | Androgen modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0514469A true BRPI0514469A (pt) | 2008-06-10 |
Family
ID=35478214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0514469-8A BRPI0514469A (pt) | 2004-08-18 | 2005-08-05 | moduladores de androgênio |
Country Status (7)
Country | Link |
---|---|
US (1) | US20080064745A1 (pt) |
EP (1) | EP1781599A1 (pt) |
JP (1) | JP2008509986A (pt) |
BR (1) | BRPI0514469A (pt) |
CA (1) | CA2573457A1 (pt) |
MX (1) | MX2007001248A (pt) |
WO (1) | WO2006018732A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7507860B2 (en) | 2004-04-13 | 2009-03-24 | Pfizer Inc. | Androgen modulators |
JP2007533726A (ja) | 2004-04-22 | 2007-11-22 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | アンドロゲンモジュレーター |
WO2006006065A1 (en) | 2004-07-08 | 2006-01-19 | Warner-Lambert Company Llc | Androgen modulators |
JP2008509983A (ja) * | 2004-08-18 | 2008-04-03 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | アンドロゲンモジュレーター |
TW200724139A (en) | 2005-05-05 | 2007-07-01 | Warner Lambert Co | Androgen modulators |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1741761A (en) * | 1923-11-08 | 1929-12-31 | Merck & Co Inc | Quinine compound and process of making the same |
US4029493A (en) * | 1973-02-23 | 1977-06-14 | Mobil Oil Corporation | Substituted phenoxybenzonitriles as herbicides |
FR2397387A1 (fr) * | 1976-04-27 | 1979-02-09 | Serobiologiques Lab Sa | 4,4'-bis-formyl-polyhalo-diphenoxyalcanes, procede de preparation et application a la synthese de 4,4'-dicyano-polyhalo-diphenoxyalcanes |
US4234595A (en) * | 1977-07-13 | 1980-11-18 | Mead Johnson & Company | 3-Indolyl-tertiary butylaminopropanols |
DE3382646D1 (de) * | 1982-08-26 | 1993-01-28 | Merck Patent Gmbh | Cyclohexanderivate und ihre verwendung als komponenten fluessigkristalliner-dielektrika. |
US4536321A (en) * | 1983-02-18 | 1985-08-20 | Chisso Corporation | Fluorobenzene derivatives and liquid crystal compositions containing the same |
US4992433A (en) * | 1987-11-23 | 1991-02-12 | Janssen Pharmaceutica N.V. | Novel pyridazinamine derivatives |
US5316755A (en) * | 1993-02-02 | 1994-05-31 | Sterling Winthrop Inc. | Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract |
TW262553B (pt) * | 1994-03-17 | 1995-11-11 | Hitachi Seisakusyo Kk | |
DE19534209A1 (de) * | 1995-09-15 | 1997-03-20 | Jenapharm Gmbh | Hormonales Mittel zur Behandlung der Haut |
ES2127106B1 (es) * | 1996-03-21 | 1999-11-16 | Menarini Lab | Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos. |
US5847166A (en) * | 1996-10-10 | 1998-12-08 | Massachusetts Institute Of Technology | Synthesis of aryl ethers |
US5800624A (en) * | 1996-10-22 | 1998-09-01 | University Of Notre Dame | Membrane process for separating carbohydrates |
US6071957A (en) * | 1996-11-27 | 2000-06-06 | The University Of Tennessee Research Corporation | Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer |
US7060331B2 (en) * | 2000-07-13 | 2006-06-13 | Merck Patent Gmbh | Chiral compounds 1 |
JP2005525337A (ja) * | 2002-02-15 | 2005-08-25 | アンドルシェルシュ・インコーポレイテッド | ビフェニル誘導体およびその抗アンドロゲン薬としての使用 |
CA2476651A1 (en) * | 2002-02-28 | 2003-09-12 | The University Of Tennessee Research Corporation | Irreversible selective androgen receptor modulators and methods of use thereof |
US6875438B2 (en) * | 2002-04-27 | 2005-04-05 | Aventis Pharma Deutschland Gmbh | Preparations for topical administration of substances having antiandrogenic activity |
KR100783255B1 (ko) * | 2004-02-13 | 2007-12-06 | 워너-램버트 캄파니 엘엘씨 | 안드로젠 수용체 조절제 |
WO2006006065A1 (en) * | 2004-07-08 | 2006-01-19 | Warner-Lambert Company Llc | Androgen modulators |
JP2008509983A (ja) * | 2004-08-18 | 2008-04-03 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | アンドロゲンモジュレーター |
-
2005
- 2005-08-05 MX MX2007001248A patent/MX2007001248A/es not_active Application Discontinuation
- 2005-08-05 BR BRPI0514469-8A patent/BRPI0514469A/pt not_active IP Right Cessation
- 2005-08-05 JP JP2007526614A patent/JP2008509986A/ja not_active Withdrawn
- 2005-08-05 EP EP05800644A patent/EP1781599A1/en not_active Withdrawn
- 2005-08-05 US US11/572,743 patent/US20080064745A1/en not_active Abandoned
- 2005-08-05 CA CA002573457A patent/CA2573457A1/en not_active Abandoned
- 2005-08-05 WO PCT/IB2005/002832 patent/WO2006018732A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP1781599A1 (en) | 2007-05-09 |
MX2007001248A (es) | 2007-03-23 |
WO2006018732A1 (en) | 2006-02-23 |
JP2008509986A (ja) | 2008-04-03 |
US20080064745A1 (en) | 2008-03-13 |
CA2573457A1 (en) | 2006-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY31274A1 (es) | Composiciones de recubrimiento electrodepositable que contiene una guanidina ciclica | |
SV2009003392A (es) | Aril pirrolidinas insecticidas | |
UA112281C2 (uk) | Стабільні інсектицидні композиції і способи їх отримання | |
ECSP10010722A (es) | Compuestos orgánicos | |
CR9346A (es) | Celulas estromaticas de adulto derivadas de tejido adiposo que exhiben caracteristicas de celulas endoteliales | |
BR112012014082A2 (pt) | composições e métodos que compreendem variantes de protease | |
CL2011000835A1 (es) | Compuestos derivados de espiro-oxindol; moduladores de los canales de sodio; composicion farmaceutica que comprende a dicho compuesto; y uso en el tratamiento del dolor, depresion, enfermedades cardiovasculares, respiratorias, psiquiatricas, entre otras. | |
DK2134691T3 (da) | Quinolinonderivativer som parp- og tank-inhibitorer | |
ATE473744T1 (de) | Modifizierte pyrimidin-glucocorticoid-rezeptor- modulatoren | |
CR9081A (es) | Inhibidores de la interaccion entre mdm2 y p53 | |
GT200800276A (es) | Composiciones farmaceuticas estabilizadas que comprenden fesoterodina | |
ECSP11010812A (es) | Complejo de mineral-aminoácido polisacárido | |
SV2009003221A (es) | Composiciones de fenilalquilamino carbamato ref. prd2743svpct | |
NO20060021L (no) | Trelim | |
ES2422275T3 (es) | Derivado del oxindol sustituido y su uso como un modulador del receptor de la vasopresina | |
ATE459620T1 (de) | Benzimidazolthiophenverbindungen als plk- modulatoren | |
BRPI1015043A2 (pt) | derivados de diazahomoadamantano e métodos de uso dos mesmos | |
PA8796901A1 (es) | Inhibidores de la interaccion entre mdm2 y p53 | |
BRPI0620229A8 (pt) | formulação | |
UY31688A1 (es) | Plaguicidas | |
WO2010054286A3 (en) | Substituted hydroxyphenylamine compounds | |
BRPI0514469A (pt) | moduladores de androgênio | |
TR201906145T4 (tr) | Faktör VII bileşimi. | |
BRPI0620985B1 (pt) | composição farmacêutica, e usos de derivados de triazina e sensibilizadores de insulina | |
PA8792401A1 (es) | Fenilendiaminas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |